USP39 and hepatocellular carcinoma: Although it was reported that USP39 did not have ubiquitin-specific peptidase activity [31], it contained a ubiquitin-protease domain, which allowed it to inhibit the degradation of ZEB1 through deubiquitination activity and thus promote the progression of HCC.